{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:05:31Z","timestamp":1775279131595,"version":"3.50.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.semnephrol.2023.151438","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T09:47:33Z","timestamp":1699609653000},"page":"151438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Approach to Diagnosis and Management of Hypertension: A Comprehensive and Combined Pediatric and Adult Perspective"],"prefix":"10.1016","volume":"43","author":[{"given":"Sabine","family":"Karam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline Abou","family":"Jaoude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FangChao Linda","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anika","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot Koranteng","family":"Tannor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Chanchlani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.semnephrol.2023.151438_bib0001","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"issue":"10304","key":"10.1016\/j.semnephrol.2023.151438_bib0003","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(21)01688-3","article-title":"Global and national high blood pressure burden and control","volume":"398","author":"Nguyen","year":"2021","journal-title":"Lancet"},{"issue":"10304","key":"10.1016\/j.semnephrol.2023.151438_bib0004","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0005","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151438_bib0006","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamapediatrics.2019.3310","article-title":"Global prevalence of hypertension in children: a systematic review and meta-analysis","volume":"173","author":"Song","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151438_bib0007","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension","volume":"18","author":"Zhou","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151438_bib0008","doi-asserted-by":"crossref","first-page":"194","DOI":"10.24095\/hpcdp.36.9.03","article-title":"Childhood overweight and obesity trends in Canada","volume":"36","author":"Rao","year":"2016","journal-title":"Health Promot Chronic Dis Prev Can."},{"key":"10.1016\/j.semnephrol.2023.151438_bib0009","unstructured":"Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks, 2009, World Health Organization, 62. Accessed on October 31st, 2023."},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0010","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/HYPERTENSIONAHA.115.05702","article-title":"Healthcare costs attributable to hypertension: Canadian population-based cohort study","volume":"66","author":"Weaver","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151438_bib0011","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/HYPERTENSIONAHA.119.14168","article-title":"Elevated blood pressure in childhood or adolescence and cardiovascular outcomes in adulthood: a systematic review","volume":"75","author":"Yang","year":"2020","journal-title":"Hypertension"},{"issue":"10022","key":"10.1016\/j.semnephrol.2023.151438_bib0012","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151438_bib0013","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1542\/peds.84.4.633","article-title":"Childhood risk factors for high adult blood pressure: the Muscatine study","volume":"84","author":"Lauer","year":"1989","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151438_bib0014","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0895-7061(95)00116-7","article-title":"Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study","volume":"8","author":"Bao","year":"1995","journal-title":"Am J Hypertens"},{"issue":"23","key":"10.1016\/j.semnephrol.2023.151438_bib0015","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.semnephrol.2023.151438_bib0016","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/CIRCULATIONAHA.107.730366","article-title":"Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis","volume":"117","author":"Chen","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0017","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ekir.2022.02.018","article-title":"High blood pressure in children and adolescents: current perspectives and strategies to improve future kidney and cardiovascular health","volume":"7","author":"Robinson","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"20","key":"10.1016\/j.semnephrol.2023.151438_bib0018","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa2109191","article-title":"Childhood cardiovascular risk factors and adult cardiovascular events","volume":"386","author":"Jacobs","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0019","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/j.ackd.2019.02.003","article-title":"Hypertension in children and adolescents","volume":"26","author":"Samuels","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"issue":"33","key":"10.1016\/j.semnephrol.2023.151438_bib0020","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151438_bib0021","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"2 suppl 4th report","key":"10.1016\/j.semnephrol.2023.151438_bib0022","first-page":"555","article-title":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151438_bib0023","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","article-title":"2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents","volume":"34","author":"Lurbe","year":"2016","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0024","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/HYPERTENSIONAHA.119.12653","article-title":"Aligning adult and pediatric blood pressure guidelines","volume":"73","author":"Gidding","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00467-010-1755-z","article-title":"Hypertension in infancy: diagnosis, management and outcome","volume":"27","author":"Dionne","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151438_bib0026","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s004670050771","article-title":"Neonatal hypertension: diagnosis and management","volume":"14","author":"Flynn","year":"2000","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0027","first-page":"1","article-title":"Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland","volume":"79","year":"1987","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ajh.2008.338","article-title":"Evaluating the accuracy of an aneroid sphygmomanometer in a clinical trial setting","volume":"22","author":"Ma","year":"2009","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0029","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/ajh.2010.232","article-title":"Assessing blood pressure accuracy of an aneroid sphygmomanometer in a national survey environment","volume":"24","author":"Ostchega","year":"2011","journal-title":"Am J Hypertens"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151438_bib0030","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jash.2014.08.014","article-title":"Oscillometric blood pressure: a review for clinicians","volume":"8","author":"Alpert","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0031","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1542\/peds.99.6.e10","article-title":"A standard protocol for blood pressure measurement in the newborn","volume":"99","author":"Nwankwo","year":"1997","journal-title":"Pediatrics."},{"issue":"17","key":"10.1016\/j.semnephrol.2023.151438_bib0032","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Bigger","year":"2010","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.semnephrol.2023.151438_bib0033","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0034","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cjca.2017.03.005","article-title":"Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults","volume":"33","author":"Leung","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.20213210S113a","article-title":"Risk of subclinical cardiovascular outcomes in children with ambulatory hypertension: a systematic review and meta-analysis","volume":"32","author":"Chung","year":"2021","journal-title":"JASN."},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151438_bib0036","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11906-016-0687-9","article-title":"White coat hypertension: to treat or not to treat?","volume":"18","author":"Cuspidi","year":"2016","journal-title":"Curr Hypertens Rep"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151438_bib0037","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00467-002-0990-3","article-title":"White coat effect and white coat hypertension in pediatric patients","volume":"17","author":"Matsuoka","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0038","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13052-016-0213-3","article-title":"White coat hypertension in pediatrics","volume":"42","author":"Jurko","year":"2016","journal-title":"Ital J Pediatr"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151438_bib0039","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/HYPERTENSIONAHA.117.08902","article-title":"Cardiovascular risk associated with white-coat hypertension: con side of the argument","volume":"70","author":"Asayama","year":"2017","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151438_bib0040","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","article-title":"European Society of Hypertension position paper on ambulatory blood pressure monitoring","volume":"31","author":"O'Brien","year":"2013","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0041","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jama.1988.03720020027031","article-title":"How common is white coat hypertension?","volume":"259","author":"Pickering","year":"1988","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0042","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/2047487318802692","article-title":"Masked hypertension incidence and risk factors in a prospective cohort study","volume":"26","author":"Trudel","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0043","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ajkd.2019.08.030","article-title":"Blood pressure measurement: a KDOQI perspective","volume":"75","author":"Drawz","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151438_bib0044","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MBP.0000000000000555","article-title":"Masked hypertension and correlation between body composition and nighttime blood pressure parameters in children and adolescents with obesity","volume":"26","author":"Rujirakan","year":"2021","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IBPC.S128947","article-title":"Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis","volume":"11","author":"Palla","year":"2018","journal-title":"Integr Blood Press Control"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151438_bib0046","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1097\/HJH.0b013e3282ef6185","article-title":"Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis","volume":"25","author":"Fagard","year":"2007","journal-title":"J Hypertens"},{"issue":"9798","key":"10.1016\/j.semnephrol.2023.151438_bib0047","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(11)61184-7","article-title":"Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study","volume":"378","author":"Lovibond","year":"2011","journal-title":"Lancet Lond Engl"},{"issue":"16","key":"10.1016\/j.semnephrol.2023.151438_bib0048","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/jama.2021.4987","article-title":"Screening for hypertension in adults: US Preventive Services Task Force Reaffirmation Recommendation Statement","volume":"325","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0049","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/HYP.0000000000000007","article-title":"Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association","volume":"63","author":"Flynn","year":"2014","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151438_bib0050","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1161\/HYP.0000000000000215","article-title":"Ambulatory blood pressure monitoring in children and adolescents: 2022 update: a scientific statement from the American Heart Association","volume":"79","author":"Flynn","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0051","series-title":"Screening for hypertension in adults: an updated systematic evidence review for the U.S. Preventive Services Task Force [Internet]","author":"Guirguis-Blake","year":"2021"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0052","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12872-020-01736-2","article-title":"Diagnostic performance of clinic and home blood pressure measurements compared with ambulatory blood pressure: a systematic review and meta-analysis","volume":"20","author":"Karnjanapiboonwong","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0053","doi-asserted-by":"crossref","first-page":"d3621","DOI":"10.1136\/bmj.d3621","article-title":"Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review","volume":"342","author":"Hodgkinson","year":"2011","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151438_bib0054","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/jch.13275","article-title":"Ambulatory blood pressure monitoring in the 21st century","volume":"20","author":"O'Brien","year":"2018","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0055","unstructured":"American Medical Association. US blood pressure validated device listing. Accessed February 3, 2023. https:\/\/www.validatebp.org"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0056","unstructured":"STRIDE BP. Validated blood pressure monitors. Accessed February 3, 2023. https:\/\/stridebp.org\/bp-monitors"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0057","unstructured":"Hypertension Canada. Blood pressure devices. Accessed February 3, 2023. https:\/\/hypertension.ca\/bpdevices"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151438_bib0058","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41371-022-00675-z","article-title":"Wearable blood pressure measurement devices and new approaches in hypertension management: the digital era","volume":"36","author":"Konstantinidis","year":"2022","journal-title":"J Hum Hypertens"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0059","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children","volume":"36","author":"Rabi","year":"2020","journal-title":"Can J Cardiol"},{"issue":"18","key":"10.1016\/j.semnephrol.2023.151438_bib0060","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1001\/jama.2020.20122","article-title":"Screening for high blood pressure in children and adolescents: US Preventive Services Task Force recommendation statement","volume":"324","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0061","unstructured":"UK National Screening Committee. Evidence map on screening for primary hypertension in children and young people. 2022. Accessed October 31st, 2023. https:\/\/view-health-screening-recommendations.service.gov.uk\/hypertension-child\/"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0062","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/pch\/pxab081","article-title":"Pediatric hypertension screening and recognition in primary care clinics in Canada","volume":"27","author":"Ding","year":"2022","journal-title":"Paediatr Child Health"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151438_bib0063","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jama.298.8.874","article-title":"Underdiagnosis of hypertension in children and adolescents","volume":"298","author":"Hansen","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0064","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1751-7176.2009.00195.x","article-title":"Secondary hypertension in overweight and stage 1 hypertensive children: a Midwest Pediatric Nephrology Consortium report","volume":"12","author":"Kapur","year":"2010","journal-title":"J Clin Hypertens"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151438_bib0065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00467-012-2344-0","article-title":"The changing face of pediatric hypertension in the era of the childhood obesity epidemic","volume":"28","author":"Flynn","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.semnephrol.2023.151438_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.543309","article-title":"Overview of monogenic forms of hypertension combined with hypokalemia","volume":"8","author":"Lu","year":"2021","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151438_bib0067","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11\u03b2\u2013hydroxysteroid dehydrogenase","volume":"10","author":"Mune","year":"1995","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0068","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/ijms19030812","article-title":"Liddle syndrome: review of the literature and description of a new case","volume":"19","author":"Tetti","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6357","key":"10.1016\/j.semnephrol.2023.151438_bib0069","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric ll\u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0071","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0072","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0073","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151438_bib0123","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00467-021-05246-x","article-title":"Monogenic forms of low-renin hypertension: clinical and molecular insights","volume":"37","author":"Khandelwal","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"19","key":"10.1016\/j.semnephrol.2023.151438_bib0074","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","article-title":"Secondary arterial hypertension: when, who, and how to screen?","volume":"35","author":"Rimoldi","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151438_bib0075","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/HYPERTENSIONAHA.112.197525","article-title":"Clinical and demographic characteristics of children with hypertension","volume":"60","author":"Flynn","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0076","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ajh\/hpu083","article-title":"Essential hypertension vs. secondary hypertension among children","volume":"28","author":"Gupta-Malhotra","year":"2015","journal-title":"Am J Hypertens"},{"issue":"19","key":"10.1016\/j.semnephrol.2023.151438_bib0077","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","author":"Peppard","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151438_bib0078","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41440-020-0468-3","article-title":"Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension","volume":"43","author":"Morimoto","year":"2020","journal-title":"Hypertens Res"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0079","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1378\/chest.13-0085","article-title":"Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial","volume":"144","author":"Pedrosa","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0124","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00467-018-3977-4","article-title":"Neonatal hypertension: cases, causes, and clinical approach","volume":"34","author":"Starr","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0125","series-title":"Hypertension in Children and Adolescents","first-page":"119","article-title":"Causes of secondary hypertension in children and adolescents","author":"Lalji","year":"2019"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40885-016-0050-0","article-title":"Clinical assessment of hypertension in children","volume":"22","author":"Patel","year":"2016","journal-title":"Clin Hypertens"},{"issue":"suppl 4","key":"10.1016\/j.semnephrol.2023.151438_bib0127","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.4103\/2230-8210.86980","article-title":"Pediatric endocrine hypertension","volume":"15","author":"Bhavani","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151438_bib0128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41397-018-0062-0","article-title":"Iatrogenic hypertension: a bioinformatic analysis","volume":"19","author":"Botzer","year":"2019","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/er.2017-00054","article-title":"Screening for endocrine hypertension: an Endocrine Society Scientific Statement","volume":"38","author":"Young","year":"2017","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151438_bib0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11906-020-01106-5","article-title":"What is the most common cause of secondary hypertension?: an interdisciplinary discussion","volume":"22","author":"Almeida","year":"2020","journal-title":"Curr Hypertens Rep"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151438_bib0131","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","article-title":"Hypertension management in older and frail older patients","volume":"124","author":"Benetos","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jamainternmed.2021.6819","article-title":"Prevalence of medications that may raise blood pressure among adults with hypertension in the United States","volume":"182","author":"Vitarello","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0081","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jaccao.2019.11.009","article-title":"Hypertension in cancer patients and survivors","volume":"1","author":"Cohen","year":"2019","journal-title":"JACC CardioOncol"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151438_bib0082","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jacc.2015.07.025","article-title":"Vascular and metabolic implications of novel targeted cancer therapies","volume":"66","author":"Li","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151438_bib0083","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/HJH.0000000000000384","article-title":"Out-of-office blood pressure and target organ damage in children and adolescents: a systematic review and meta-analysis","volume":"32","author":"Kollias","year":"2014","journal-title":"J Hypertens"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151438_bib0084","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/jch.12608","article-title":"Is daytime systolic load an important risk factor for target organ damage in pediatric hypertension?","volume":"17","author":"Conkar","year":"2015","journal-title":"J Clin Hypertens"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0002-9394(14)72260-3","article-title":"The prevalence of retinal vascular abnormalities in children and adolescents with essential hypertension","volume":"111","author":"Daniels","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0086","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00246-006-1390-4","article-title":"Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension","volume":"28","author":"Assadi","year":"2007","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151438_bib0087","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151438_bib0088","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/jch.14236","article-title":"Non-pharmacological management of hypertension","volume":"23","author":"Verma","year":"2021","journal-title":"J Clin Hypertens"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0089","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/HYPERTENSIONAHA.111.00831","article-title":"Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988\u20132008","volume":"62","author":"Rosner","year":"2013","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0090","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1662","article-title":"Change in weight status and development of hypertension","volume":"137","author":"Parker","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0091","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/01.HYP.0000245672.27270.4a","article-title":"Importance of salt in determining blood pressure in children: meta-analysis of controlled trials","volume":"48","author":"He","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0092","first-page":"233","article-title":"Evidence for exercise training in the management of hypertension in adults","volume":"61","author":"Ghadieh","year":"2015","journal-title":"Can Fam Physician"},{"issue":"18","key":"10.1016\/j.semnephrol.2023.151438_bib0093","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.113.005666","article-title":"Effect of childhood obesity prevention programs on blood pressure: a systematic review and meta-analysis","volume":"129","author":"Cai","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0094","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cjca.2017.03.007","article-title":"Hypertension Canada's 2017 guidelines for the diagnosis, assessment, prevention, and treatment of pediatric hypertension","volume":"33","author":"Dionne","year":"2017","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00467-002-0851-0","article-title":"Beta-blocker\/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial","volume":"17","author":"Sorof","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0132","series-title":"Hypertension in Children and Adolescents","first-page":"268","article-title":"Evidence from clinical trials and use of antihypertensive drugs in children and adolescents","author":"Redon","year":"2019"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0133","series-title":"Kaplan's Clinical Hypertension","first-page":"198","article-title":"Treatment of hypertension: drug therapy","author":"Kaplan","year":"2014"},{"key":"10.1016\/j.semnephrol.2023.151438_bib0134","series-title":"Pediatric Hypertension","first-page":"544","article-title":"Pharmacologic treatment of childhood hypertension","author":"Ferguson","year":"2013"},{"issue":"17","key":"10.1016\/j.semnephrol.2023.151438_bib0097","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"W\u00fchl","year":"2009","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.semnephrol.2023.151438_bib0098","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0099","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151438_bib0100","doi-asserted-by":"crossref","first-page":"73S","DOI":"10.1016\/S0895-7061(98)00060-0","article-title":"The role of combination therapy in the treatment of hypertension","volume":"11","author":"Moser","year":"1998","journal-title":"Am J Hypertens"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151438_bib0101","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1097\/HJH.0000000000002096","article-title":"Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Salam","year":"2019","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151438_bib0102","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/HYPERTENSIONAHA.117.09801","article-title":"Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014","volume":"70","author":"Zhang","year":"2017","journal-title":"Hypertension"},{"issue":"10008","key":"10.1016\/j.semnephrol.2023.151438_bib0103","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151438_bib0104","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151438_bib0105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41371-019-0207-x","article-title":"Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study","volume":"33","author":"Ito","year":"2019","journal-title":"J Hum Hypertens"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0106","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/HYPERTENSIONAHA.121.17073","article-title":"Effect of KBP-5074 on blood pressure in advanced chronic kidney disease: results of the BLOCK-CKD study","volume":"78","author":"Bakris","year":"2021","journal-title":"Hypertension"},{"issue":"23","key":"10.1016\/j.semnephrol.2023.151438_bib0107","doi-asserted-by":"crossref","first-page":"13415","DOI":"10.1073\/pnas.96.23.13415","article-title":"Aminopeptidase A inhibitors as potential central antihypertensive agents","volume":"96","author":"Reaux","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6163","key":"10.1016\/j.semnephrol.2023.151438_bib0108","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"issue":"10367","key":"10.1016\/j.semnephrol.2023.151438_bib0109","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(22)02034-7","article-title":"Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial","volume":"400","author":"Schlaich","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0110","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1152\/ajpendo.00121.2014","article-title":"A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats","volume":"307","author":"Andreassen","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7404","key":"10.1016\/j.semnephrol.2023.151438_bib0111","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0112","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jash.2014.11.001","article-title":"SGLT2 inhibitors: their potential reduction in blood pressure","volume":"9","author":"Maliha","year":"2015","journal-title":"J Am Soc Hypertens"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151438_bib0113","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamacardio.2022.3904","article-title":"Effects of renal denervation vs sham in resistant hypertension after medication escalation: prespecified analysis at 6 months of the RADIANCE-HTN TRIO randomized clinical trial","volume":"7","author":"Azizi","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"24","key":"10.1016\/j.semnephrol.2023.151438_bib0114","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1016\/j.jcin.2020.09.054","article-title":"12-Month results from the unblinded phase of the RADIANCE-HTN SOLO trial of ultrasound renal denervation","volume":"13","author":"Azizi","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151438_bib0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41440-022-01042-8","article-title":"Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial","volume":"46","author":"Kario","year":"2023","journal-title":"Hypertens Res"},{"issue":"10333","key":"10.1016\/j.semnephrol.2023.151438_bib0116","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(22)00455-X","article-title":"Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial","volume":"399","author":"Mahfoud","year":"2022","journal-title":"Lancet"},{"issue":"10234","key":"10.1016\/j.semnephrol.2023.151438_bib0117","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.semnephrol.2023.151438_bib0118","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.jacc.2013.02.048","article-title":"Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial)","volume":"61","author":"Gurvitz","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151438_bib0119","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ackd.2021.11.005","article-title":"When hypertension grows up: implications for transitioning care of adolescents and young adults with hypertension from pediatric to adult health care providers","volume":"29","author":"Mannemuddhu","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151438_bib0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1367493519831493","article-title":"Health literacy, nutrition knowledge, and health care transition readiness in youth with chronic kidney disease or hypertension: a cross-sectional study","volume":"24","author":"Zhong","year":"2020","journal-title":"J Child Health Care"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151438_bib0121","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00467-011-1981-z","article-title":"Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA)","volume":"26","author":"Watson","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151438_bib0122","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3517","article-title":"Research gaps in primary pediatric hypertension","volume":"143","author":"Taylor-Zapata","year":"2019","journal-title":"Pediatrics"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:50:22Z","timestamp":1748357422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929523001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0270929523001481"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151438","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to Diagnosis and Management of Hypertension: A Comprehensive and Combined Pediatric and Adult Perspective","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151438"}}